
EP Edge® Journal Watch: Issue 43 November 2026: VT Ablation, Idiopathic VF, His-Bundle Pacing and Endocarditis
Episode 50
EP Edge® Journal Watch 43 | November 2026: VT Ablation, Idiopathic VF, His-Bundle Pacing and Endocarditis How should we judge new ventricular ablation technologies, reassess survivors of apparently idiopathic ventricular fibrillation, and weigh the long-term consequences of pacing and infection-management decisions? In Issue 43 of EP Edge Journal Watch, Dr. Sharma examines ventricular arrhythmias, cardiac resynchronization, implanted-device safety, and infective endocarditis. Four featured discussions cover CLEAR-VT with its companion device analysis, long-term outcomes after idiopathic ventricular fibrillation, His-Alternative I, and the American Heart Association’s endocarditis scientific statement, including the POET trial. Shorter reviews address focal pulsed field ablation, arrhythmogenic cardiomyopathy, Brugada syndrome, pacing-induced ventricular dysfunction, device-related infection risk, and cardiovascular nutrition. The episode is designed for cardiac electrophysiologists, cardiologists, fellows, and allied professionals seeking critical appraisal and practical clinical interpretation. Articles are listed below in newsletter order. Dasa: CLEAR-VT and Dual-Energy Lattice-Tip Ablation of Ventricular Arrhythmias. Featured discussion. Early US experience demonstrates procedural feasibility in a selected, challenging population.
Publisher
EP Edge Journal Watch: Cardiac Electrophysiology Research
Link
share.transistor.fm/s/720aa437
Published
November 2, 2026
Duration
28 min
Format
Podcast
Category
Issues · Science
Source
RSS feed
Host
Niraj Sharma MD FACC FHRS: Cardiac Electrophysiology & Cardiology
EP Edge Journal Watch: Cardiac Electrophysiology Research
@epedgejournalwatchcardiacele
#vtablation #idiopathicvf #bundlepacing #lifesciences #medicine
